Alok K. Tewari

3.0k total citations
35 papers, 1.1k citations indexed

About

Alok K. Tewari is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Alok K. Tewari has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Alok K. Tewari's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). Alok K. Tewari is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Cancer Genomics and Diagnostics (6 papers). Alok K. Tewari collaborates with scholars based in United States, Canada and Germany. Alok K. Tewari's co-authors include Phillip G. Febbo, Leon Sun, Judd W. Moul, Thomas J. Polascik, Cary N. Robertson, Florian R. Schroeck, Tracey L. Krupski, David Albala, Marva M. Price and William T. Barry and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Alok K. Tewari

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alok K. Tewari United States 12 503 365 233 219 130 35 1.1k
Luis Sierrasesúmaga Spain 24 367 0.7× 522 1.4× 323 1.4× 177 0.8× 66 0.5× 65 1.3k
Han Kyeom Kim South Korea 22 349 0.7× 429 1.2× 391 1.7× 142 0.6× 97 0.7× 83 1.3k
John R. Houck United States 16 330 0.7× 161 0.4× 138 0.6× 179 0.8× 109 0.8× 22 771
Karey Shumansky Canada 15 495 1.0× 268 0.7× 369 1.6× 243 1.1× 115 0.9× 20 1.3k
Milena Braga‐Basaria United States 12 254 0.5× 467 1.3× 212 0.9× 136 0.6× 43 0.3× 21 1.2k
Jian Gong China 22 396 0.8× 290 0.8× 262 1.1× 212 1.0× 95 0.7× 84 1.4k
Tao Xu China 19 535 1.1× 252 0.7× 252 1.1× 302 1.4× 24 0.2× 138 1.2k
Stephanie Hsu United States 10 471 0.9× 110 0.3× 164 0.7× 231 1.1× 36 0.3× 21 909
Stefan Wilop Germany 21 631 1.3× 100 0.3× 237 1.0× 130 0.6× 188 1.4× 48 1.1k
Amy P. Webster United Kingdom 7 609 1.2× 126 0.3× 116 0.5× 162 0.7× 53 0.4× 11 879

Countries citing papers authored by Alok K. Tewari

Since Specialization
Citations

This map shows the geographic impact of Alok K. Tewari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok K. Tewari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok K. Tewari more than expected).

Fields of papers citing papers by Alok K. Tewari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok K. Tewari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok K. Tewari. The network helps show where Alok K. Tewari may publish in the future.

Co-authorship network of co-authors of Alok K. Tewari

This figure shows the co-authorship network connecting the top 25 collaborators of Alok K. Tewari. A scholar is included among the top collaborators of Alok K. Tewari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok K. Tewari. Alok K. Tewari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyahira, Andrea K., Marina N. Sharifi, Lisa N. Chesner, et al.. (2024). Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey‐Holden Prostate Cancer Academy Meeting. The Prostate. 85(3). 211–226. 1 indexed citations
2.
Banda, Kondwani Joseph, et al.. (2024). 748P Phase II dose optimization with EZH2/EZH1 inhibitor tulmimetostat in patients with ARID1A-mutated ovarian clear cell carcinoma. Annals of Oncology. 35. S567–S568. 1 indexed citations
3.
Ravi, Praful, Wanling Xie, Himisha Beltran, et al.. (2024). Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer. European Urology Oncology. 8(3). 709–715. 1 indexed citations
4.
5.
Drilon, Alexander, Alexander I. Spira, Monica Sharma, et al.. (2023). 682P Preclinical and ongoing phase I study data of the CHK1 inhibitor BBI-355 in development for patients with oncogene amplification on extrachromosomal DNA (ecDNA). Annals of Oncology. 34. S477–S477. 1 indexed citations
6.
Yim, Kendrick, Christopher J. Magnani, Adam S. Feldman, et al.. (2023). Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer. Urologic Oncology Seminars and Original Investigations. 41(12). 489.e1–489.e6. 1 indexed citations
7.
Choudhury, Atish D., Wanling Xie, Alok K. Tewari, et al.. (2022). A phase Ia/Ib study of talazoparib in combination with tazemetostat in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 40(16_suppl). TPS5098–TPS5098. 1 indexed citations
8.
Luo, Kaixuan, Alexias Safi, Linda K. Hong, et al.. (2022). Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data. Genome Research. 32(6). 1183–1198. 2 indexed citations
9.
10.
Wang, Jun, Thomas F. Westbrook, C. Ryan Miller, et al.. (2020). An Animal Model of MYC-Driven Medulloblastoma. UNC Libraries.
11.
Zerillo, Jessica A., Benjamin A. Goldenberg, Ritesh R. Kotecha, et al.. (2017). Interventions to improve oral chemotherapy safety and quality: A systematic and grey literature review.. Journal of Clinical Oncology. 35(8_suppl). 97–97. 1 indexed citations
12.
Zerillo, Jessica A., Benjamin A. Goldenberg, Ritesh R. Kotecha, et al.. (2017). Interventions to Improve Oral Chemotherapy Safety and Quality. JAMA Oncology. 4(1). 105–105. 63 indexed citations
13.
Tewari, Alok K. & Daniel J. George. (2013). Novel chemotherapies in development for management of castration-resistant prostate cancer. Current Opinion in Urology. 23(3). 220–229. 6 indexed citations
14.
Knelson, Erik H., et al.. (2013). Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma. Journal of Clinical Investigation. 123(11). 4786–4798. 38 indexed citations
15.
Klink, Joseph C., Alok K. Tewari, Elizabeth M. Masko, et al.. (2012). Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell‐line specific manner, through paradoxical effects on oncogenic pathways. The Prostate. 73(7). 754–762. 30 indexed citations
16.
Shibata, Yoichiro, Nathan C. Sheffield, Olivier Fédrigo, et al.. (2012). Extensive Evolutionary Changes in Regulatory Element Activity during Human Origins Are Associated with Altered Gene Expression and Positive Selection. PLoS Genetics. 8(6). e1002789–e1002789. 90 indexed citations
17.
Pei, Yanxin, Colin E. Moore, Jun Wang, et al.. (2012). An Animal Model of MYC-Driven Medulloblastoma. Cancer Cell. 21(2). 155–167. 211 indexed citations
18.
Mavropoulos, John C., W. Cooper Buschemeyer, Alok K. Tewari, et al.. (2009). The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model. Cancer Prevention Research. 2(6). 557–565. 86 indexed citations
19.
Bibiłło, Arkadiusz, Daniela Lener, Alok K. Tewari, & Stuart F.J. Le Grice. (2005). Interaction of the Ty3 Reverse Transcriptase Thumb Subdomain with Template-Primer. Journal of Biological Chemistry. 280(34). 30282–30290. 8 indexed citations
20.
Boyd, Lawrence M., William J. Richardson, Jun Chen, et al.. (2005). Osmolarity Regulates Gene Expression in Intervertebral Disc Cells Determined by Gene Array and Real-Time Quantitative RT-PCR. Annals of Biomedical Engineering. 33(8). 1071–1077. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis Sierrasesúmaga Breakdown of academic impact, for papers by Han Kyeom Kim Breakdown of academic impact, for papers by John R. Houck Breakdown of academic impact, for papers by Karey Shumansky Breakdown of academic impact, for papers by Milena Braga‐Basaria Breakdown of academic impact, for papers by Jian Gong Breakdown of academic impact, for papers by Tao Xu Breakdown of academic impact, for papers by Stephanie Hsu Breakdown of academic impact, for papers by Stefan Wilop Breakdown of academic impact, for papers by Amy P. Webster
Rankless by CCL
2026